ANALOGIFREMGANGSMAATE VED FREMSTILLING AV TERAPEUTISK AKTIVE OCTAHYDROINDOLO-(2,3-A)-KINOLIZIN-1-YL-ALKANCARBOKSYLSYREAMIDER OG SYREADDISJONSSALTER DERAV

The invention relates to new 1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-1-yl-alkanecarboxylic acid amides of the general formula (I),whereinR, and R2 represent a hydrogen or halogen atom, or a hydroxyl, nitro or C1-4 alkoxy group;R3 and R4 represent a hydrogen atom or a C1-4 alkyl group;R5...

Full description

Saved in:
Bibliographic Details
Main Authors KUTHI, CSABA, MATUZ, JUDIT, SZPORNY, LASZLO, BALOGH, ZSUZSANNA, EZER, ELEMER, SZANTAY, CSABA, SOETI, FERENC, INCZE, MARIA, HAJOS, GYOERGY
Format Patent
LanguageNorwegian
Published 26.06.1989
Edition4
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to new 1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-1-yl-alkanecarboxylic acid amides of the general formula (I),whereinR, and R2 represent a hydrogen or halogen atom, or a hydroxyl, nitro or C1-4 alkoxy group;R3 and R4 represent a hydrogen atom or a C1-4 alkyl group;R5 and R6 represent a hydrogen atom, C1-8 alkyl group, C3-8 alkenyl or cycloalkyl group, aryl or aralkyl group, heteroaryl or heteroaralkyl goup containing oxygen, nitrogen or sulphur atom, all these goups being optionally substituted; orR5 and R6 together represent a,w-alkyl group, wherein one carbon atom may optionally be replaced by an oxygen or nitrogen atom; andG means a C1-4 straight chained alkylidene group, as well as to their therapeutically useful acid addition salts and pharmaceutical compositions containing these compounds.Furthermore, the invention relates to a process for preparing these compounds and compositions.The compounds of the general formula (I) have valuable therapeutic properties, namely vasodilatory, spasmolytic, antiarrhythmic and gastrocytoprotective effects. The gastrocytoprotective effect is particularly important.
Bibliography:Application Number: NO19850003936